跳至主要内容
临床试验/NCT05778305
NCT05778305已完成早期 1 期

Effect of Dexmedetomidine on Stress-induced Changes in Hemodynamics and Left Ventricular Function in Coronary Artery Bypass Graft Surgery Outcome

Ain Shams University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年1月29日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
50
试验地点
1
主要终点
post-operative ventricular function.

研究概览

简要总结

50 patients of both sexes undergoing elective CABG surgery will be randomly divided into 2 groups, study group (Dex) group and control group (C) to determine the effect of dexmedetomidine on the peri-operative hemodynamic changes during CABG surgery.

详细描述

The effect of dexmedetomidine during CABG surgery is studied regarding Ventricular function, pre bypass and post bypass using the transoeophageal echo (TEE), post-operative by transthoracic echocardiography (TTE) on day of surgery and after extubation.

Incidence of intraoperative and post operative ischemia and arrhythmias using Electrocardiogram (ECG) as well as the length of ICU and hospital stay.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • undergoing elective CABG surgery

排除标准

  • Patient refusal
  • Dementia patients
  • Poor ventricular function with ejection fraction below 40%
  • Asthmatic patients
  • Uncontrolled diabetic patients with HbA1c above 8
  • Combined surgeries (CABG+ valves)
  • Emergency surgeries.
  • Pre-existing arrhythmia
  • Patients with renal impairment
  • Patients with hepatic impairment
  • Patients with heart block
  • Off-pump CABG

研究组 & 干预措施

Dexmedetomidine group

Active Comparator

patients will have loading Dexmedetomidine( 1ug/kg) over 10 minutes followed by continuous infusion of (0.5ug/kg/hr) from the initiation of anaesthesia up to extubation in the ICU. Patients will not be extubated until completely awake and have no sign of arrhythmias and bleeding

干预措施: Dexmedetomidine (Drug)

control group

Placebo Comparator

patients will receive the same volume of 0.9% saline infusion as loading and maintenance infusion.

干预措施: normal saline (Other)

结局指标

主要结局

post-operative ventricular function.

时间窗: Up to 24 hours postoperative

global systolic function Ejection Fraction by TTE postoperative

Intra-operative ventricular function.

时间窗: Intraoperative

global systolic function Ejection Fraction by TEE intraoperative

次要结局

  • hemodynamics(Immediate postoperative and up to 24 hours postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rania Maher Hussien, MD

Associate professor of Anesthesia

Ain Shams University

研究点 (1)

Loading locations...

相似试验